Literature DB >> 15750622

Selective inhibition of TGF-beta responsive genes by Smad-interacting peptide aptamers from FoxH1, Lef1 and CBP.

Qiqi Cui1, Sang Kyun Lim, Bryan Zhao, Francis Michael Hoffmann.   

Abstract

Transforming growth factor beta (TGF-beta) stimulation results in the assembly of Smad-containing protein complexes that mediate activation or repression of TGF-beta responsive genes. To determine if disruption of specific Smad protein-protein interactions would selectively inhibit responses to TGF-beta or generally interfere with Smad-dependent signaling, we developed three Smad-binding peptide aptamers by introducing Smad interaction motifs from Smad-binding proteins CBP, FoxH1 and Lef1 into the scaffold protein E. coli thioredoxin A (Trx). All three classes of aptamers bound to Smads by GST pulldown assays and co-immunoprecipitation from mammalian cells. Expression of the aptamers in HepG2 cells did not generally inhibit Smad-dependent signaling as evaluated using seven TGF-beta responsive luciferase reporter genes. The Trx-xFoxH1b aptamer inhibited TGF-beta-induced expression from a reporter dependent on the Smad-FoxH1 interaction, A3-lux, by 50%. Trx-xFoxH1b also partially inhibited two reporters not dependent on a Smad-FoxH1 interaction, 3TP-lux and Twntop, and endogenous PAI-1 expression. Trx-Lef1 aptamer only inhibited expression of the Smad-Lef1 responsive reporter gene TwnTop. The Trx-CBP aptamer had no significant effect on reporter gene expression. The results suggest that Smad-binding peptide aptamers can be developed to selectively inhibit TGF-beta-induced gene expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15750622     DOI: 10.1038/sj.onc.1208556

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

1.  Expanding the available assays: adapting and validating In-Cell Westerns in microfluidic devices for cell-based assays.

Authors:  Amy L Paguirigan; John P Puccinelli; Xiaojing Su; David J Beebe
Journal:  Assay Drug Dev Technol       Date:  2010-07-26       Impact factor: 1.738

2.  Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.

Authors:  Yong-Hun Lee; William P Schiemann
Journal:  Breast Cancer Manag       Date:  2014

3.  Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA.

Authors:  Bryan M Zhao; F Michael Hoffmann
Journal:  Mol Biol Cell       Date:  2006-06-14       Impact factor: 4.138

4.  Genetic and functional evidence implicating DLL1 as the gene that influences susceptibility to visceral leishmaniasis at chromosome 6q27.

Authors:  Michaela Fakiola; E Nancy Miller; Manal Fadl; Hiba S Mohamed; Sarra E Jamieson; Richard W Francis; Heather J Cordell; Christopher S Peacock; Madhuri Raju; Eltahir A Khalil; Ahmed Elhassan; Ahmed M Musa; Fernando Silveira; Jeffrey J Shaw; Shyam Sundar; Selma M B Jeronimo; Muntaser E Ibrahim; Jenefer M Blackwell
Journal:  J Infect Dis       Date:  2011-08-01       Impact factor: 5.226

5.  TGF-β in the Bone Microenvironment: Role in Breast Cancer Metastases.

Authors:  Jeroen T Buijs; Keith R Stayrook; Theresa A Guise
Journal:  Cancer Microenviron       Date:  2011-07-12

Review 6.  Targeting the transforming growth factor-beta signaling pathway in human cancer.

Authors:  Nagathihalli S Nagaraj; Pran K Datta
Journal:  Expert Opin Investig Drugs       Date:  2010-01       Impact factor: 6.206

7.  Peptide aptamer identified by molecular docking targeting translationally controlled tumor protein in leukemia cells.

Authors:  Onat Kadioglu; Thomas Efferth
Journal:  Invest New Drugs       Date:  2016-03-14       Impact factor: 3.850

8.  Benzyl isothiocyanate inhibits breast cancer cell tumorigenesis via repression of the FoxH1-Mediated Wnt/β-catenin pathway.

Authors:  Yantao Liu; Lingli Zhang; Yao Meng; Liang Huang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 9.  Antitransforming growth factor-beta therapy in fibrosis: recent progress and implications for systemic sclerosis.

Authors:  John Varga; Boris Pasche
Journal:  Curr Opin Rheumatol       Date:  2008-11       Impact factor: 5.006

10.  Hedgehog pathway responsiveness correlates with the presence of primary cilia on prostate stromal cells.

Authors:  Jingxian Zhang; Robert J Lipinski; Jerry J Gipp; Aubie K Shaw; Wade Bushman
Journal:  BMC Dev Biol       Date:  2009-10-07       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.